Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N.   Gaw A.   Scherbakova O.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency

By Zebrack J.S.   Anderson J.L.   Beddhu S.   for the Intermountain Heart Collaborative Study Group.  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 30-30

Elsevier

Access to resources Recommend Favorite

C-reactive protein and coronary events following percutaneous coronary angioplasty

By de Winter R.J.   Koch K.T.   van Straalen J.P.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 49-50

Elsevier

Access to resources Recommend Favorite

C-reactive Protein, Lung Hyperinflation and Heart Rate Variability in Chronic Obstructive Pulmonary Disease -A Pilot Study

By Corbo Giuseppe Maria  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 2, 2013-03 ,pp. : 200-207

Informa Healthcare

Access to resources Recommend Favorite

Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease

By Anderson R.   Dart A.M.   Starr J.   Shaw J.   Chin-Dusting J.P.F.  

Atherosclerosis, Vol. 172, Iss. 2, 2004-02 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite